Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New target-seeking molecule offers hope of better cancer treatment

21.04.2006


A new target-seeking affibody molecule can be used to visualize cancer tumors and to treat them. This has been shown in a dissertation by Ann-Charlott Steffen to be publicly defended at Uppsala University on April 22.


The gamma camera image shows the distribution of radioactivity in a mouse given target-seeking affibody molecules marked with radioactivity. The uptake can be seen in the thyroid gland, the kidneys, and the tumor.



Every third Swede is estimated to receive a cancer diagnosis sometime in their lives, and nearly one Swede in four dies as a result of the disease. The need for improved detection and treatment of the disease is great.

Existing treatments include surgery, chemotherapy, and radiation. Surgery is most effective for large, well-defined tumors, but if the disease has spread, chemotherapy and/or radiation are needed. These forms of treatment affect all dividing cells, leading to toxic effects on healthy tissue. This toxicity limits the size of the dose that can be given, thereby also limiting the probability that the disease will be cured. By seeking out tumor cells and selectively delivering cytostatics or radiation to the cancer cells, the dose affecting healthy tissue can be reduced and the dose to the tumor can be increased. This improves the chances of curing the disease.


Ann-Charlott Steffen and her associates have developed an affibody molecule that binds to the protein HER-2, which primarily occurs in cancer cells from patients with aggressive forms of breast cancer. The scientists have attached radioactivity to the affibody molecules, so that they can visualize tumors and metastases and also treat tumors with the local dose of radiation provided by this radioactivity.

Ann-Charlott Steffen shows that the HER-2-binding affibody molecules attach to cancer cells with the HER-2 target on their surface, both in cell cultures and in mouse tumors. The research team has also found that the radioactivity in mouse tumors can be used to make these tumors visible in a gamma camera (see picture). Moreover, the results show that the radioactivity delivered by the affibody molecules can be used to kill tumor cells in cell cultures.

Affibody molecules are tiny, which enables them to enter tumors and be rapidly distributed in the body, unlike antibodies, which are normally used in target-seeking therapy and visualization. What’s more, affibody molecules are relatively easy to develop for virtually any target and can therefore in all probability be used for visualizing and treating many different forms of cancer.

“I hope these findings will lead to new possibilities of visualizing and treating distributed tumor diseases so that more cancer patients will be able to survive,” says Ann-Charlott Steffen.

Linda Nohrstedt | alfa
Further information:
http://info.uu.se/press.nsf/pm/new.targetseeking.idAE4.html

More articles from Health and Medicine:

nachricht Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>